FAGLIGE KONKLUSIONER OG BEGRUNDELSER FOR ÆNDRING AF MARKEDSFØRINGSTILLADELSEN FOR PROCOMVAX FREMLAGT AF EMEA
SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION OF THE MARKETING AUTHORISATION OF PROCOMVAX PRESENTED BY THE EMEA